For some women with HIV, protease inhibitors may add to diabetes risk

07/2/2014 | Aidsmap

A study in the journal AIDS found that protease inhibitor-based therapy was associated with an increased likelihood of the development of diabetes in some women with a genetic risk for the condition. The study highlights the need for individualized HIV/AIDS regimens based on genetic risk factors, researchers said.

View Full Article in:

Aidsmap

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD